Vir Biotechnology, Inc. Quarterly Costs and Expenses in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Vir Biotechnology, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2021 to Q3 2024.
  • Vir Biotechnology, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $234M, a 23.4% increase year-over-year.
  • Vir Biotechnology, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $688M, a 15.6% decline year-over-year.
  • Vir Biotechnology, Inc. annual Costs and Expenses for 2023 was $770M, a 1.56% decline from 2022.
  • Vir Biotechnology, Inc. annual Costs and Expenses for 2022 was $783M, a 16% increase from 2021.
  • Vir Biotechnology, Inc. annual Costs and Expenses for 2021 was $675M, a 80.7% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $688M $234M +$44.3M +23.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $643M $162M -$57.3M -26.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $701M $136M -$69.9M -33.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $770M $156M -$44.1M -22.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $815M $189M +$9.78M +5.45% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $805M $219M +$34.4M +18.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $770M $206M -$12.3M -5.63% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $783M $200M -$41.1M -17.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $824M $180M +$22.6M +14.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $801M $185M +$68.5M +59.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $733M $219M +$58M +36.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $675M $241M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $157M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $116M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $161M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.